WW News & Events

Reports Q1 revenue $168.26M, consensus $158.53M. "We remain confident in our strategy to build the industry-leading weight health platform. Our focus is on executing high-impact initiatives that drive Clinical growth and stabilize our Behavioral business," said Jon Volkmann, Chief Operations Officer and member of the Company's Interim Office of the Chief Executive. "We made encouraging progress in Q1, with End of Period Clinical Subscribers growing 51% sequentially, and Core+, our higher value Behavioral tier that includes expert support and community experiences, returning to year-over-year growth."

Backs FY26 adjusted EBITDA view $105M-$115M. "We are pleased with our Q1 results. Adjusted Gross Margin2 remains near record highs as we continue to drive operational efficiencies across our portfolio of businesses," said Felicia DellaFortuna, Chief Financial Officer and member of the Company's Interim Office of the Chief Executive. "We are reaffirming our 2026 Revenue and Adjusted EBITDA guidance and expect Adjusted EBITDA and cash generation to increase in the remaining quarters of 2026. Our strengthened capital structure, including the recently announced debt prepayment actions, position us to execute on our transformation while maintaining financial discipline."

The major averages had a mixed close amid stalled peace negotiations between the U.S. and Iran as well as new escalation in the Strait of Hormuz. Investors are also balancing continued strength in corporate earnings and AI-driven optimism with rising geopolitical tension and macro uncertainty.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Verizonprovided areport for Q1Domino's Pizzareportedand announced an additional $1B share repurchase programShellARC Resourcesfor C$32.80 per shareSun PharmaOrganonfor $14 per share in an all-cash transactionChina has blocked Meta's2. WALL STREET CALLS:Snapto Buy at Rothschild & Co RedburnRothschildPinterestto Neutral from BuyMizuhoAdobeon intensifying competition from AIMizuhoCrowdStrike, citing "numerous exciting growth avenues"Campbell'sto Market Perform at Bernstein3. AROUND THE WEB:Rogers Communicationsis offering voluntary buyouts to half of its staff, Globe and Mail reportsGoogleemployees are urging CEO Sundar Pichai to block military AI use, FT reportsSamsungplans to withdraw from China's home appliance and television market this year, Nikkei Asia reportsBig tech companies are preparing to spend hundreds of billions of dollars on AI infrastructure, with most of their plans dependent on ASML, WSJ saysBayeris hoping the U.S. Supreme Court can reduce or simplify the lawsuits over its Roundup weedkiller and potentially corral litigation that has cost the company over $10B, Bloomberg says4. MOVERS:Veradermicsgained after announcing its Phase 2/3 trial of VDPHL01RE/MAX Holdingsincreased after announcing it will befor $13.80 per shareFlowserve (FLS) rose afterthat Starboard has built a stake in the company and is pushing for changesCompass Therapeuticswas lower afterfrom its COMPANION-002 studyPoet Technologiesfell afterof Celestial AI purchase orders5. EARNINGS/GUIDANCE:Lakeland Financial, with CEO David Findlay commenting, "We started 2026 with robust, record net income for the second consecutive quarter"HBT Financial, with EPS and revenue beating consensusRepay Holdingsreportedand reaffirmed its guidance for FY26WWreaffirmed itsand FY26 financial guidanceGold RoyaltyreportedINDEXES:The Dow fell 62.92, or 0.13%, to 49,167.79, the Nasdaq gained 50.50, or 0.20%, to 24,887.10, and the S&P 500 advanced 8.83, or 0.12%, to 7,173.91.